GX-E4

DRUG2 trials

Sponsors

Genexine Inc.

Conditions

Anemia in patients with chronic kidney disease on dialysis

Phase 3

A Phase III, Randomized, Investigator-Blinded, Active-Controlled Study of Efficacy and Safety of Efepoetin Alfa for Treatment of Anemia in Patients with Chronic Kidney Disease on Dialysis

WithdrawnCTIS2023-503634-50-00

Genexine Inc.Anemia in patients with chronic kidney disease on dialysis

Target: 222Updated: 2024-02-11

A Phase III, Randomized, Investigator-Blinded, Active-Controlled Study of Efficacy and Safety of Efepoetin Alfa for Treatment of Anemia in Patients with Chronic Kidney Disease on Dialysis

RecruitingCTIS2023-503634-50-01

Genexine Inc.Anemia in patients with chronic kidney disease on dialysis

Start: 2025-07-22Target: 272Updated: 2026-01-19